Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Core Scientific, Inc./txXPDB · Entity 389 | General Counsel and Secretary | December 09, 2021 | December 10, 2021 |
| XAI Floating Rate & Alternative Income TrustXFLT · Entity 5990 | Officer of XAI | December 08, 2021 | December 09, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Core Scientific, Inc./tx
Report date December 09, 2021 · Filed December 10, 2021
This filing explicitly reported no securities owned.
XAI Floating Rate & Alternative Income Trust
Report date December 08, 2021 · Filed December 09, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares of Beneficial OwnershipSEC Table I · non-derivative | Direct | 42,851 |
Reported balance
After 2021-12-08 transaction · row 1
1 source rowRow 1 · 2021-12-08 · Sale · Disposed 11,100 · Balance 42,851 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2021 Filed Dec 9, 2021 17:25 UTC | XAI Floating Rate & Alternative Income Trust XFLT · Entity 5990 | SaleCommon Shares of Beneficial Ownership | 11,100 | $9.10 | $101,010.00 |
DisclosureSEC source: 0001718129-21-000001 · primary_doc.xml · nonDerivative · entry 1 McGarrity John P · CIK 0001718129 · Officer of XAI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,851 Read SEC document |
| March 16, 2020 Filed Mar 16, 2020 17:01 UTC | XAI Floating Rate & Alternative Income Trust XFLT · Entity 5990 | PurchaseCommon Shares of Beneficial Interest | 2,520 | $5.54 | $13,954.25 |
DisclosureSEC source: 0001718129-20-000001 · primary_doc.xml · nonDerivative · entry 1 McGarrity John P · CIK 0001718129 · Chief Legal & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,951 Read SEC document |
| March 20, 2018 Filed Mar 20, 2018 18:16 UTC | XAI Floating Rate & Alternative Income Trust XFLT · Entity 5990 | PurchaseCommon Shares of Beneficial Interest | 359 | $9.58 | $3,439.94 |
DisclosureSEC source: 0001718129-18-000003 · primary_doc.xml · nonDerivative · entry 1 McGarrity John P · CIK 0001718129 · Chief Legal & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,431 Read SEC document |
| February 07, 2018 Filed Feb 8, 2018 16:50 UTC | XAI Floating Rate & Alternative Income Trust XFLT · Entity 5990 | PurchaseCommon Shares of Beneficial Interest | 352 | $9.75 | $3,432.28 |
DisclosureSEC source: 0001718129-18-000002 · primary_doc.xml · nonDerivative · entry 1 McGarrity John P · CIK 0001718129 · Chief Legal & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,072 Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 15:20 UTC | XAI Floating Rate & Alternative Income Trust XFLT · Entity 5990 | PurchaseCommon Shares of Beneficial Interest | 720 | $9.43 | $6,789.02 |
DisclosureSEC source: 0001718129-18-000001 · primary_doc.xml · nonDerivative · entry 1 McGarrity John P · CIK 0001718129 · Chief Legal & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,720 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.